Fig 1.
Flow-chart for selection of study participants.
Table 1.
Baseline characteristics of patients diagnosed with benign prostatic hyperplasia and general population without benign prostatic hyperplasia.
Table 2.
Number of suicide death and suicide rates in patients diagnosed with benign prostatic hyperplasia and general population without benign prostatic hyperplasia.
Table 3.
Hazard ratios (95% CI) for suicide among patients with benign prostatic hyperplasia compared to general population without benign prostatic hyperplasia.
Table 4.
Hazard ratios (95% CI) for suicide among patients with benign prostatic hyperplasia according to different age groups.